a public good project by the
Synthesis
Company
of California

© 2026

Yasuo Ohashi | doi.page

0 works0 citations0 h-index

Yasuo Ohashi

Chuo University(JP)

Publications by Year

Research Areas

Cancer Treatment and Pharmacology, Colorectal Cancer Treatments and Studies, Breast Cancer Treatment Studies, Diabetes, Cardiovascular Risks, and Lipoproteins, Lung Cancer Treatments and Mutations

Most-Cited Works

→ Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine(2007)2,500 cited
→ Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials(2010)2,426 cited
→ Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy(2017)1,840 cited
→ Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer(2011)1,465 cited
→ Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials(2017)1,113 cited
→ Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)(2016)1,108 cited

→ Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial(2006)955 cited

→ Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial(2000)848 cited

→ Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan(2006)635 cited

→ Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study(2013)629 cited